Form D Explorer

Form C-AR — Phoenix PharmaLabs, Inc.

0001755778-24-000001 · filed May 7, 2024

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

CIK
1755778
Entity
Corporation
Jurisdiction
UT
Address
909 N 400 W
North Salt Lake, UT 84054
Phone
—

Most recent fiscal year financials

Total assets
$796,285
Cash
—
Short-term debt
—
Long-term debt
$5,328,028
Revenues
$2,065,804
COGS
—
Taxes paid
—
Net income
$-884,105

View the original filing on SEC EDGAR ↗